PT - JOURNAL ARTICLE AU - Meghana Halkar AU - A. Michael Lincoff TI - Dual antiplatelet therapy for acute coronary syndromes: How long to continue? AID - 10.3949/ccjm.83a.15092 DP - 2016 Sep 01 TA - Cleveland Clinic Journal of Medicine PG - 675--688 VI - 83 IP - 9 4099 - http://www.ccjm.org/content/83/9/675.short 4100 - http://www.ccjm.org/content/83/9/675.full SO - Cleve Clin J Med2016 Sep 01; 83 AB - For patients with an acute coronary syndrome event, current guidelines recommend dual antiplatelet therapy for at least 12 months after drug-eluting stent placement. However, several clinical trials have assessed whether continuing dual antiplatelet therapy beyond 12 months is beneficial. We review the pros and cons of extending dual antiplatelet therapy.